mirror of
https://github.com/msberends/AMR.git
synced 2026-01-11 08:34:41 +01:00
Built site for AMR@3.0.1.9008: 9d1b456
This commit is contained in:
@@ -135,7 +135,7 @@ TZP (piperacillin/tazobactam) is "R":
|
||||
#> 1. If TZP is "R" then set to "R":
|
||||
#> amoxicillin (AMX), ampicillin (AMP), azlocillin (AZL), mezlocillin (MEZ), piperacillin (PIP), piperacillin/tazobactam (TZP)
|
||||
|
||||
These 35 antimicrobial groups are allowed in the rules
|
||||
These 38 antimicrobial groups are allowed in the rules
|
||||
(case-insensitive) and can be used in any combination:
|
||||
|
||||
- aminoglycosides
|
||||
@@ -148,7 +148,7 @@ These 35 antimicrobial groups are allowed in the rules
|
||||
tobramycin-high)
|
||||
|
||||
- aminopenicillins
|
||||
(amoxicillin and ampicillin)
|
||||
(amoxicillin, amoxicillin/clavulanic acid, and ampicillin)
|
||||
|
||||
- antifungals
|
||||
(amorolfine, amphotericin B, amphotericin B-high, anidulafungin,
|
||||
@@ -171,6 +171,18 @@ These 35 antimicrobial groups are allowed in the rules
|
||||
aminosalicylate, streptomycin/isoniazid, terizidone, thioacetazone,
|
||||
thioacetazone/isoniazid, tiocarlide, and viomycin)
|
||||
|
||||
- betalactamase_inhibitors
|
||||
(amoxicillin/clavulanic acid, amoxicillin/sulbactam,
|
||||
ampicillin/sulbactam, avibactam, aztreonam/avibactam,
|
||||
aztreonam/nacubactam, cefepime/enmetazobactam, cefepime/nacubactam,
|
||||
cefepime/taniborbactam, cefepime/tazobactam, cefepime/zidebactam,
|
||||
cefoperazone/sulbactam, cefotaxime/sulbactam, ceftaroline/avibactam,
|
||||
ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam,
|
||||
meropenem/nacubactam, meropenem/vaborbactam, mezlocillin/sulbactam,
|
||||
nacubactam, penicillin/sulbactam, piperacillin/sulbactam,
|
||||
piperacillin/tazobactam, sulbactam, sultamicillin, taniborbactam,
|
||||
tazobactam, ticarcillin/clavulanic acid, and zidebactam)
|
||||
|
||||
- betalactams
|
||||
(amoxicillin, amoxicillin/clavulanic acid, amoxicillin/sulbactam,
|
||||
ampicillin, ampicillin/sulbactam, apalcillin, aspoxicillin,
|
||||
@@ -338,16 +350,18 @@ These 35 antimicrobial groups are allowed in the rules
|
||||
and oxacillin screening test)
|
||||
|
||||
- lincosamides
|
||||
(clindamycin, lincomycin, and pirlimycin)
|
||||
(clindamycin, clindamycin inducible screening test, lincomycin, and
|
||||
pirlimycin)
|
||||
|
||||
- lipoglycopeptides
|
||||
(dalbavancin, oritavancin, and telavancin)
|
||||
|
||||
- macrolides
|
||||
(acetylmidecamycin, acetylspiramycin, azithromycin, clarithromycin,
|
||||
dirithromycin, erythromycin, flurithromycin, gamithromycin, josamycin,
|
||||
kitasamycin, meleumycin, midecamycin, miocamycin, nafithromycin,
|
||||
oleandomycin, rokitamycin, roxithromycin, solithromycin, spiramycin,
|
||||
clindamycin inducible screening test, dirithromycin, erythromycin,
|
||||
flurithromycin, gamithromycin, josamycin, kitasamycin, meleumycin,
|
||||
midecamycin, miocamycin, nafithromycin, oleandomycin, pirlimycin,
|
||||
primycin, rokitamycin, roxithromycin, solithromycin, spiramycin,
|
||||
telithromycin, tildipirosin, tilmicosin, troleandomycin,
|
||||
tulathromycin, tylosin, and tylvalosin)
|
||||
|
||||
@@ -382,6 +396,9 @@ These 35 antimicrobial groups are allowed in the rules
|
||||
- phenicols
|
||||
(chloramphenicol, florfenicol, and thiamphenicol)
|
||||
|
||||
- phosphonics
|
||||
(amikacin/fosfomycin and fosfomycin)
|
||||
|
||||
- polymyxins
|
||||
(colistin, polymyxin B, and polymyxin B/polysorbate 80)
|
||||
|
||||
@@ -396,17 +413,20 @@ These 35 antimicrobial groups are allowed in the rules
|
||||
nalidixic acid, nalidixic acid screening test, nemonoxacin,
|
||||
nifuroquine, nitroxoline, norfloxacin, norfloxacin screening test,
|
||||
norfloxacin/metronidazole, norfloxacin/tinidazole, ofloxacin,
|
||||
ofloxacin/ornidazole, orbifloxacin, oxolinic acid, pazufloxacin,
|
||||
pefloxacin, pefloxacin screening test, pipemidic acid, piromidic acid,
|
||||
pradofloxacin, premafloxacin, prulifloxacin, rosoxacin, rufloxacin,
|
||||
sarafloxacin, sitafloxacin, sparfloxacin, temafloxacin, tilbroquinol,
|
||||
tioxacin, tosufloxacin, and trovafloxacin)
|
||||
ofloxacin/ornidazole, orbifloxacin, oxolinic acid, ozenoxacin,
|
||||
pazufloxacin, pefloxacin, pefloxacin screening test, pipemidic acid,
|
||||
piromidic acid, pradofloxacin, premafloxacin, prulifloxacin,
|
||||
rosoxacin, rufloxacin, sarafloxacin, sitafloxacin, sparfloxacin,
|
||||
temafloxacin, tilbroquinol, tioxacin, tosufloxacin, and trovafloxacin)
|
||||
|
||||
- rifamycins
|
||||
(rifabutin, rifampicin, rifampicin/ethambutol/isoniazid,
|
||||
rifampicin/isoniazid, rifampicin/pyrazinamide/ethambutol/isoniazid,
|
||||
rifampicin/pyrazinamide/isoniazid, rifamycin, and rifapentine)
|
||||
|
||||
- spiropyrimidinetriones
|
||||
(zoliflodacin)
|
||||
|
||||
- streptogramins
|
||||
(pristinamycin and quinupristin/dalfopristin)
|
||||
|
||||
@@ -456,10 +476,10 @@ x
|
||||
#> A set of custom EUCAST rules:
|
||||
#>
|
||||
#> 1. If AMC is R and genus is "Klebsiella" then set to R :
|
||||
#> amoxicillin (AMX), ampicillin (AMP)
|
||||
#> amoxicillin (AMX), amoxicillin/clavulanic acid (AMC), ampicillin (AMP)
|
||||
#>
|
||||
#> 2. If AMC is I and genus is "Klebsiella" then set to I :
|
||||
#> amoxicillin (AMX), ampicillin (AMP)
|
||||
#> amoxicillin (AMX), amoxicillin/clavulanic acid (AMC), ampicillin (AMP)
|
||||
|
||||
# run the custom rule set (verbose = TRUE will return a logbook instead of the data set):
|
||||
eucast_rules(example_isolates,
|
||||
@@ -490,10 +510,10 @@ x2
|
||||
#> A set of custom EUCAST rules:
|
||||
#>
|
||||
#> 1. If AMC is R and genus is "Klebsiella" then set to R :
|
||||
#> amoxicillin (AMX), ampicillin (AMP)
|
||||
#> amoxicillin (AMX), amoxicillin/clavulanic acid (AMC), ampicillin (AMP)
|
||||
#>
|
||||
#> 2. If AMC is I and genus is "Klebsiella" then set to I :
|
||||
#> amoxicillin (AMX), ampicillin (AMP)
|
||||
#> amoxicillin (AMX), amoxicillin/clavulanic acid (AMC), ampicillin (AMP)
|
||||
#>
|
||||
#> 3. If TZP is R then set to R :
|
||||
#> biapenem (BIA), doripenem (DOR), ertapenem (ETP), imipenem (IPM),
|
||||
|
||||
Reference in New Issue
Block a user